id: NEW:hdv_rna_positive_status_to_NEW:hepatocellular_carcinoma_incidence
name: Hepatitis Delta Virus RNA Positive Status â†’ Hepatocellular Carcinoma Incidence
from_node:
  node_id: NEW:hdv_rna_positive_status
  node_name: Hepatitis Delta Virus RNA Positive Status
to_node:
  node_id: NEW:hepatocellular_carcinoma_incidence
  node_name: Hepatocellular Carcinoma Incidence
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Active HDV replication (HDV RNA+ status) in hepatocytes leads to persistent
  and severe hepatic inflammation compared to HBV monoinfection'
- 'Step 2: Chronic inflammation accelerates hepatocyte damage, oxidative stress, and
  compensatory cellular proliferation'
- 'Step 3: Progressive liver fibrosis develops more rapidly, leading to compensated
  and then decompensated cirrhosis'
- 'Step 4: The cirrhotic microenvironment with ongoing inflammation, regenerative
  nodule formation, and genomic instability promotes hepatocarcinogenesis'
- 'Step 5: Increased rate of hepatocellular carcinoma (HCC) development in HDV RNA+
  patients compared to HDV RNA- patients'
evidence:
  quality_rating: A
  n_studies: 12
  primary_citation: 'Robert G. Gish et al. 2023. "Association of hepatitis delta virus
    with liver morbidity and mortality: A systematic literature review and meta-analysis."
    Hepatology.'
  supporting_citations: []
description: 'Hepatitis Delta Virus RNA positive status is significantly associated
  with increased risk of hepatocellular carcinoma in patients co-infected with HBV.
  A meta-analysis of 12 studies found that HDV RNA+ patients have nearly 3-fold higher
  risk of HCC (HR 2.97, 95% CI: 1.87-4.70) compared to HDV RNA- patients. This increased
  risk is mediated through accelerated liver disease progression, with HDV RNA+ status
  also associated with higher rates of compensated cirrhosis, decompensated cirrhosis,
  liver transplantation, and liver-related mortality.'
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 2.97
    type: hazard_ratio
    ci_lower: 1.87
    ci_upper: 4.7
  p_value: null
  sample_size: null
moderators:
- name: Cirrhosis status
  direction: strengthens
  strength: strong
  description: Progression through compensated cirrhosis (RR 1.74) to decompensated
    cirrhosis (HR 3.82) represents an intermediate pathway that amplifies HCC risk
